Abstract:Synthetic analogs of 1,4-anthraquinone (AQ code number), which block nucleoside transport, decrease DNA, RNA and protein syntheses, trigger cytochrome c release without caspase activation, induce apoptotic DNA fragmentation and inhibit the proliferation of wild-type and multidrug resistant tumor cells in the nM range in vitro, rapidly cause the collapse of mitochondrial transmembrane potential in cell and cell-free systems. Because mitochondrial permeability transition (MPT) requires more than depolarization to occur, antitumor AQs were tested for their ability to directly trigger specific markers of MPT in isolated mitochondria. In contrast to a spectrum of conventional anticancer drugs that are inactive, various AQs interact with isolated mitochondria in a concentration- and time-dependent manner to rapidly cause large amplitude swelling and Ca2+ release in relation with their effectiveness against L1210, HL-60 and LL/2 tumor cells in vitro. Indeed, the lead antitumor AQ8, AQ9 and AQ 17 are also the most effective inducers of MPT in isolated mitochondria, whereas all AQ derivatives devoid of anti-proliferative activity also fail to trigger mitochondrial swelling and Ca2+ release. Moreover, the ability of 4 mu M AQ17 to maximally induce mitochondrial swelling and Ca2+ release within 15 min is similar to that of classic MPT-inducing agents, such as 5 mu g/ml alamethicin, 200 mu M atractyloside, 5 mu M phenylarsine oxide, 100 mu M arsenic trioxide and a 100 mu M Ca2+ overload. Interestingly, AQ17 requires a priming concentration of 20 mu M Ca2+ to trigger mitochondrial swelling and Ca2+ release and these 0.1 mu M ruthenium red-sensitive MPT events are abolished by I mu M cyclosporin A, 2 mM ADP and 20 mu M bongkrekic acid, which block components of the permeability transition pore (PTP), and also inhibited by 50-100 mu M of various ubiquinones, which interact with the quinone binding site of the PTP and raise the Ca2+ load required for PTP opening. Hence, antitumor AQs that target isolated mitochondria and trigger MPT might directly interact with components of the PTP to induce conformational changes that increase its Ca2+ sensitivity and transition from the closed to the open state.

Electronic properties of anthraquinone drugs in the inner mitochondrial membrane

Exploring the Multifaceted Role of Adenosine Nucleotide Translocase 2 in Cellular and Disease Processes: A Comprehensive Review.

Inhibition of mitochondrial respiration as a source of adaphostin-induced reactive oxygen species and cytotoxicity

The role of membranes in the mechanism of action of the antineoplastic agent adriamycin. Spin-labeling studies with chronically hypoxic and drug-resistant tumor cells.

Study on Redox Properties and Cytotoxicity of Anthraquinone Derivatives to Understand Antitumor Active Anthracycline Substances

A novel thiol oxidation-based mechanism for adriamycin-induced cell injury in human macrophages

The antipsoriatic compound anthralin influences bioenergetic parameters and redox properties of energy transducing membranes

Chemical-induced Phase Transition and Global Conformational Reorganization of Chromatin

Mitochondrial proliferation during apoptosis induced by anticancer agents: effects of doxorubicin and mitoxantrone on cancer and cardiac cells

New anthraquinone drugs and their anticancer activities: Cytotoxicity, DFT, Docking and ADMET properties

In Vitro Anticancer Screening and Preliminary Mechanistic Study of A-Ring Substituted Anthraquinone Derivatives

Intracellular Accumulation, Retention, and Distribution of Anthracyclines in A Multidrug-Resistant Variant K562r

Understanding Anthracycline Cardiotoxicity From Mitochondrial Aspect

Novel Substituted 1,4-Anthracenediones With Antitumor Activity Directly Induce Permeability Transition In Isolated Mitochondria

High-resolution sub-cellular imaging by correlative NanoSIMS and electron microscopy of amiodarone internalisation by lung macrophages as evidence for drug-induced phospholipidosis

Elucidating the interplay of PPAR gamma inhibition and energy demand in adriamycin‐induced cardiomyopathy: In Vitro and In Vivo perspective

Thioridazine interacts with the membrane of mitochondria acquiring antioxidant activity toward apoptosis--potentially implicated mechanisms

Adriamycin inhibits glycolysis through downregulation of key enzymes in Saccharomyces cerevisiae

Involvement of Mitochondrial Mechanisms in the Cytostatic Effect of Desethylamiodarone in B16F10 Melanoma Cells

Targeting Mitochondria by Zn(II)N-Alkylpyridylporphyrins: The Impact of Compound Sub-Mitochondrial Partition on Cell Respiration and Overall Photodynamic Efficacy